Mettler-Toledo International Inc.

NYSE:MTD

Medical - Diagnostics & Research

Healthcare
$1,737.26 +1.47%

+$16.60 today

Market cap
$34.55B
Beta
1.26
P/E (TTM)
26.6
EPS (TTM)
$43.14
52W Low $1,023.05High $1,525.17

Volume 0.16M

Average 0.19M

MTD EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Mettler-Toledo International Inc.NYSE: MTD

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $347.2M rose 17.3% year over year, ahead of the +7.1% change in trailing-twelve-month EBITDA. Sequentially, it rose 33.9% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.

Context

  • EBITDA amounted to 30.9% of revenue in FY2025, down 1.4 pp from a year earlier.
  • EBITDA increased in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 9 analysts of $1.4B (+13.0%) for the fiscal year ending Dec 2026, a step up from the -0.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$347.2M+33.9% QoQ
Last fiscal yearDec 2025
$1.24B-0.6% YoY
LTMJun 2026
$1.31B+7.1% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17.3%+6.8%-10.5 pp
1 year-0.6%+13.0%+13.5 pp
3-year CAGR+0.1%+10.5%+10.4 pp
5-year CAGR+10.0%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
1.24B USD
Year-over-year change
-0.6%
4-year CAGR
+3.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How MTD compares with its peers on the latest reported figures

  • MTD's LTM Jun 2026 EBITDA of $1.31B is the 5th highest of the 10 companies compared; the peer median is $957.8M.
  • Its year-over-year change of +7.1% is the 4th highest of 10, against a peer median of +0.7%.
  • EBITDA amounts to 31.6% of revenue for MTD, versus a peer median of 25.3%.
MTD Competitors Peer median
EBITDA for MTD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$11.24B -0.8%-1.3%23.7%
DHRDanaher CorporationLTM Sep 2026$7.09B +3.2%-9.9%27.7%
AAgilent Technologies, Inc.LTM Jul 2026$2.04B +13.2%-1.2%27.6%
TDYTeledyne Technologies IncorporatedLTM Sep 2026$1.65B +18.0%+3.9%25.3%
MTDMettler-Toledo International Inc.LTM Jun 2026$1.31B +7.1%+0.1%31.6%
IEXIDEX CorporationLTM Jun 2026$957.8M +12.1%-0.2%26.7%
WATWaters CorporationLTM Jul 2026$950.77M -10.1%-0.2%20.5%
RVTYRevvity, Inc.LTM Jul 2026$767M -6.7%-13.5%26.3%
BRKRBruker CorporationLTM Jun 2026$247.7M -38.6%-16.4%7.1%
NOVTNovanta Inc.LTM Oct 2026$158.84M +0.7%-1.6%14.6%
Peer median (excluding MTD) $957.8M+0.7%-1.3%25.3%

Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.72B3.92B3.79B3.87B4.03B
Cost of Revenue1.61B1.68B1.62B1.62B1.64B
Gross Profit2.11B2.24B2.17B2.25B2.39B
Gross Margin56.7%57.2%57.3%58.2%59.4%
Research & Development169.77M177.12M185.28M189.36M199.37M
Selling, General & Admin943.98M938.46M904.11M936.3M998.31M
Operating Expenses1.11B1.12B1.09B1.13B1.27B
Depreciation & Amortization108.06M113.02M121.16M123.22M125.61M
EBITDA1.1B1.24B1.2B1.25B1.24B
EBITDA Margin29.7%31.6%31.7%32.3%30.9%
Operating Income994.74M1.13B1.08B1.13B1.12B
Operating Margin26.8%28.7%28.5%29.1%27.8%
Interest Income00000
Interest Expense43.24M55.39M77.37M74.63M68.52M
Other Income / Expenses(45.38M)(55.63M)(105.96M)(89.83M)(69.58M)
Income Before Tax949.36M1.07B973.73M1.04B1.05B
Pre-Tax Margin25.5%27.3%25.7%26.8%26.1%
Income Tax Expense180.38M198.09M184.95M174.08M179.72M
Net Income768.99M872.5M788.78M863.14M869.19M
Net Margin20.7%22.3%20.8%22.3%21.6%
EPS (Basic)33.2538.7936.1040.6742.17
EPS (Diluted)32.7838.4135.9040.4842.05
Weighted Avg Shares23.13M22.49M21.85M21.22M20.61M
Weighted Avg Shares (Diluted)23.46M22.72M21.97M21.32M20.67M

Mettler-Toledo International Inc.

NYSE:MTD

Intrinsic Alpha fair value

Locked

Current Price

$1,737.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.